Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 6/20 | 0.39 |
| ▸ | AMY2A | P04746 | 1/20 | 0.39 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.36 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.36 |
| ▸ | FGF1 | P05230 | 2/20 | 0.36 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.36 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.36 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.34 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.34 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.34 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.34 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.34 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.34 |
| ▸ | GJA1 | P17302 | 2/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15686020 | 0.87 | AMY2A (0.43) | GJB2AMY2ALGALS3LGALS9LGALS1 | |
| SCHEMBL20859590 | 0.87 | AMY2A (0.43) | GJB2AMY2ALGALS3LGALS9LGALS1 | |
| SCHEMBL14925558 | 0.86 | LGALS8 (0.40) | AMY2AFGF1LGALS8 | |
| SCHEMBL19184728 | 0.85 | AMY2A (0.36) | GJB2AMY2ALGALS3LGALS9LGALS1 | |
| SCHEMBL19187102 | 0.85 | AMY2A (0.36) | GJB2AMY2ALGALS3LGALS9LGALS1 | |
| SCHEMBL17447249 | 0.85 | AMY2A (0.36) | GJB2AMY2ALGALS3LGALS9LGALS1 | |
| SCHEMBL17448710 | 0.85 | AMY2A (0.36) | GJB2AMY2ALGALS3LGALS9LGALS1 | |
| SCHEMBL19341669 | 0.83 | FGF1 (0.40) | GJB2AMY2ALGALS3LGALS9LGALS1 | |
| SCHEMBL24436935 | 0.80 | FGF1 (0.39) | GJB2AMY2ALGALS3LGALS9LGALS1 | |
| SCHEMBL23306563 | 0.80 | AMY1A (0.45) | AMY2ALGALS3LGALS9LGALS1LGALS7; LGALS7B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2595480-B1 | ANTIMICROBIAL MEDICAL GEL COMPOSITION COMPRISING ETHERIFIED HYDROXYETHYLCELLULOSE | BRUSELLS VENTURES CORP (VG) | 2016-09-07 | — | — | EP | disclosed |
| US-20130116331-A1 | MEDICAL GEL | BRUSELLS VENTURES CORP. (VG) | 2013-05-09 | — | — | US | disclosed |
| US-20130116331-A1 | MEDICAL GEL | BRUSELLS VENTURES CORP. (VG) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116331-A1 | MEDICAL GEL | CUTA, SHH, POLR1C | GJB2 712/4885AMY2A 3385/4885LGALS3 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.